| Original language | English |
|---|---|
| Publication status | Published - 2005 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Do blood levels explain clinical differences between whole extract of cannabis and pure delta-9-tetrahydrocannabinol in the treatment of multiple sclerosis symptoms?
- Mel Priston
- , L. J. Teare
- , J Zajicek
- , D Wright
- Peninsula Medical School, Universities of Exeter and Plymouth
Research output: Contribution to conference › Conference paper (not formally published)